β-Blocker and survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease

Eur Heart J. 2021 Mar 21;42(12):1180. doi: 10.1093/eurheartj/ehab004.

Authors

Hui Tang¹, Zu-Yao Yang², Jin-Ling Tang^{1

2}

Affiliations

¹ Department of Clinical Data Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
² Division of Epidemiology, JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong, China.

PMID: 33495780
DOI: 10.1093/eurheartj/ehab004

No abstract available

Publication types

Comment

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Cardiovascular Diseases*
Humans
Lung

Substances

Adrenergic beta-Antagonists